Jeevan Scientific Technology (BOM:538837) Cyclically Adjusted Revenue per Share: ₹33.62 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538837 Jeevan Scientific Technology Ltd BOM:538837
69 GF Score
Price ₹73.17
GF Value ₹85.25
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jeevan Scientific Technology Cyclically Adjusted Revenue per Share?

Jeevan Scientific Technology BOM:538837 -1.36% 69 Cyclically Adjusted Revenue per Share is ₹33.62 as of Jun. 2026. GuruFocus rates BOM:538837 with a GF Score™ of 69/100 and a GF Value™ of ₹85.25 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Jeevan Scientific Technology's adjusted revenue per share for the three months ended in Jun. 2026 was ₹9.176. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹33.62 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Jeevan Scientific Technology's average Cyclically Adjusted Revenue Growth Rate was 5.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Jeevan Scientific Technology was 2.10% per year. The lowest was 2.10% per year. And the median was 2.10% per year.

As of today (2026-08-24), Jeevan Scientific Technology's current stock price is ₹73.17. Jeevan Scientific Technology's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹33.62. Jeevan Scientific Technology's Cyclically Adjusted PS Ratio of today is 2.18.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jeevan Scientific Technology was 2.61. The lowest was 1.09. And the median was 1.76.


Jeevan Scientific Technology  (BOM:538837) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Jeevan Scientific Technology's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=73.17/33.62
=2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Jeevan Scientific Technology was 2.61. The lowest was 1.09. And the median was 1.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Jeevan Scientific Technology Cyclically Adjusted Revenue per Share Related Terms


Jeevan Scientific Technology Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Jeevan Scientific Technology's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeevan Scientific Technology Cyclically Adjusted Revenue per Share Chart

Jeevan Scientific Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 31.23 31.55 31.73 33.21

Jeevan Scientific Technology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.98 32.46 32.80 33.21 33.62

BOM:538837 vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Jeevan Scientific Technology's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jeevan Scientific Technology Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jeevan Scientific Technology's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Jeevan Scientific Technology's Cyclically Adjusted PS Ratio falls into.


BOM:538837
69GF Score
Jeevan Scientific Technology Ltd BOM:538837
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeevan Scientific Technology Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jeevan Scientific Technology's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=9.176/167.3573*167.3573
=9.176

Current CPI (Jun. 2026) = 167.3573.

Jeevan Scientific Technology Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 6.882 105.961 10.870
201612 5.378 105.196 8.556
201703 5.768 105.196 9.176
201706 6.679 107.109 10.436
201709 5.362 109.021 8.231
201712 6.163 109.404 9.428
201803 3.752 109.786 5.720
201806 4.087 111.317 6.145
201809 5.040 115.142 7.326
201812 5.231 115.142 7.603
201903 2.838 118.202 4.018
201906 2.074 120.880 2.871
201909 3.440 123.175 4.674
201912 5.507 126.235 7.301
202003 5.251 124.705 7.047
202006 3.265 127.000 4.303
202009 7.985 130.118 10.270
202012 10.304 130.889 13.175
202103 9.444 131.771 11.995
202106 9.011 134.084 11.247
202109 10.505 135.847 12.942
202112 10.540 138.161 12.767
202203 14.222 138.822 17.145
202206 6.740 142.347 7.924
202209 5.221 144.661 6.040
202212 7.304 145.763 8.386
202303 5.223 146.865 5.952
202306 6.454 150.280 7.187
202309 5.226 151.492 5.773
202312 6.584 152.924 7.205
202403 6.349 153.035 6.943
202406 7.799 155.789 8.378
202409 7.643 157.882 8.102
202412 7.899 158.323 8.350
202503 6.271 157.552 6.661
202506 6.271 159.755 6.569
202509 7.818 162.289 8.062
202512 9.575 163.281 9.814
202603 12.183 164.272 12.412
202606 9.176 167.357 9.176

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹33.62 mean?
Jeevan Scientific Technology (BOM:538837) has a Cyclically Adjusted Revenue per Share of ₹33.62 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Jeevan Scientific Technology and its competitors.
Is Jeevan Scientific Technology's Cyclically Adjusted Revenue per Share too high?
Jeevan Scientific Technology's current Cyclically Adjusted Revenue per Share is ₹33.62. Overall, Jeevan Scientific Technology has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeevan Scientific Technology's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Jeevan Scientific Technology's Cyclically Adjusted Revenue per Share of ₹33.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Jeevan Scientific Technology and its competitors. Jeevan Scientific Technology's current Cyclically Adjusted Revenue per Share is ₹33.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeevan Scientific Technology stock overvalued right now?
Based on GuruFocus' analysis, Jeevan Scientific Technology (BOM:538837) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹85.25, compared to a current price of ₹73.17 — trading 14.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹33.62. Jeevan Scientific Technology's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Jeevan Scientific Technology (BOM:538837), the current Cyclically Adjusted Revenue per Share is ₹33.62 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeevan Scientific Technology (BOM:538837) Overvalued in 2026?

Based on GuruFocus' analysis, Jeevan Scientific Technology stock appears to be undervalued. The current stock price of ₹73.17 is trading 14.2% below its estimated GF Value™ of ₹85.25. GuruFocus considers Jeevan Scientific Technology to be Modestly Undervalued.

Key valuation signals for BOM:538837:

  • Cyclically Adjusted Revenue per Share: ₹33.62
  • GF Value™: ₹85.25 vs. price of ₹73.17 (14.2% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the BOM:538837 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jeevan Scientific Technology Business Description

Address Sai Krupa Enclave, Plot No. 1 and 2, Golconda Post, Near Lanco Hills, Hyderabad, TG, IND, 500008
Jeevan Scientific Technology Ltd is an India-based company engaged in providing clinical research and data management services. Jeevan Scientific is an independent clinical contract research organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various clients across the globe. Its services offer high-value testing services, including bioanalytical services for small and large molecules, ranging across generics, biosimilars, and other new drugs. It operates in a single segment, namely clinical research services.
69GF Score

Get the complete analysis for BOM:538837

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹73.17
Price
₹85.25
GF Value